PV Bulletin

Agenda of the CVMP meeting 8-10 September 2026

The agenda outlines the topics to be discussed during the CVMP meeting.

Primary source: EMA - What's new RSS

Translated From German

PV Bulletin does not take any responsibility for translation errors or omissions, though it has used the best available translation engine.

PV Impact Brief

MonitoringConfidence: high

What changed

The agenda was officially published detailing discussions planned on regulatory matters within the Committee for Veterinary Medicinal Products.

Why it matters

Clear communication and disclosure of interests during the CVMP meeting support regulatory compliance and trust within the veterinary medicinal products industry.

Action needed

Stakeholders should prepare for discussions regarding veterinary medicinal product reviews, specifically focusing on maximum residue limits and ensure all interests are declared by participants.

Relevant for
Regulatory Intelligence Lead
Processes impacted
Labeling
Owner

Regulatory Intelligence Lead

Review cadence

Review in the next regulatory intelligence cycle.

Evidence and confidence

Confidence: highSource updated: Sep 8, 2026

Full briefing

Practical implication

Stakeholders should prepare for discussions regarding veterinary medicinal product reviews, specifically focusing on maximum residue limits and ensure all interests are declared by participants.

The CVMP meeting scheduled for 8-10 September 2026 will address various veterinary medicinal product topics, including maximum residue limits and declarations of interests from committee members. Participants must declare any interests relevant to agenda items to ensure transparency and manage conflicts of interest.

What changed: The agenda was officially published detailing discussions planned on regulatory matters within the Committee for Veterinary Medicinal Products.

Why it matters: Clear communication and disclosure of interests during the CVMP meeting support regulatory compliance and trust within the veterinary medicinal products industry.

Practical implication: Stakeholders should prepare for discussions regarding veterinary medicinal product reviews, specifically focusing on maximum residue limits and ensure all interests are declared by participants.

View original source

  • Source: EMA - What's new RSS
  • Published at source: 2026-09-08T00:00:00.000Z
  • Discovered by monitor: 2026-09-08T21:36:27.459Z

Published from the regulator source ingestion pipeline after PV impact triage.

Related updates for your role

publicTrade Remedies Authority (TRA) · UK · Updated Sep 8, 2026

Provisional Anti-Dumping Measure on Chinese Glass Container Imports

Urgency: High

Importers of the affected glass containers must guarantee the payment of the anti-dumping duty for a period of six months from the effective date.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicMHRA · UK · Updated Sep 8, 2026

Iran Sanctions Legislation Update, 8 September 2026

Urgency: High

Organizations must review and update compliance protocols in response to expanded trade prohibitions and prepare for restrictions on Iranian aviation effective immediately.

Country ComplianceRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicTherapeutic Goods Administration (TGA) · Australia · Updated Sep 8, 2026

Updated classification rules for certain combination products

Urgency: High

Review and adjust labeling and compliance processes for affected combination products as per the new regulations.

Country ComplianceLabelingRegulatory Intelligence Lead
SOP Impact2 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead, Labeling Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward
publicTGA · Australia · Updated Sep 8, 2026

Clinical decision support system exemption amendments

Urgency: High

Regulatory Intelligence Leads should update their compliance checks and monitoring processes to align with the new exemption details effective from 1 November 2026.

Signal ManagementRegulatory Intelligence Lead
SOP Impact1 SOPs
ConfidenceHigh
Relevant for: Regulatory Intelligence Lead
verifiedRegulatory action: Regulators
Read impact briefarrow_forward